NCT02492516View on ClinicalTrials.gov

Intravenous Injection of Adipose Derived Mesenchymal Stem Cell for ALS

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

March 31, 2017

Study Completion Date

April 30, 2017

Conditions
Amyotrophic Lateral Sclerosis
Interventions
BIOLOGICAL

mesenchymal stem cells

mesenchymal stem cells injection via peripheral vein.

Trial Locations (1)

Unknown

Royan Institute, Tehran

All Listed Sponsors
lead

Royan Institute

OTHER_GOV

NCT02492516 - Intravenous Injection of Adipose Derived Mesenchymal Stem Cell for ALS | Biotech Hunter | Biotech Hunter